{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,10]],"date-time":"2026-08-10T14:49:53Z","timestamp":1786373393320,"version":"build-2736575974"},"reference-count":33,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"1","funder":[{"DOI":"10.13039\/501100005941","name":"Dietmar Hopp Stiftung","doi-asserted-by":"publisher","award":["1DH2111111"],"award-info":[{"award-number":["1DH2111111"]}],"id":[{"id":"10.13039\/501100005941","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":["CJASN"],"published-print":{"date-parts":[[2022,1]]},"abstract":"<jats:sec>\n                    <jats:title>Background and objectives<\/jats:title>\n                    <jats:p>\n                      Antibody response after severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) vaccination is impaired in kidney transplant recipients. Emerging variants, such as B.1.617.2 (\n                      <jats:italic toggle=\"yes\">\u03b4<\/jats:italic>\n                      ), are of particular concern because of their higher transmissibility and partial immune escape. Little is known about protection against these variants in immunocompromised patients.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Design, setting, participants, &amp; measurements<\/jats:title>\n                    <jats:p>\n                      In this prospective two-center study, antispike 1 IgG and surrogate neutralizing antibodies were measured in 173 kidney transplant recipients and 166 healthy controls with different vaccination schedules. In addition, different SARS-CoV-2 epitope antibodies from 135 vaccinated kidney transplant recipients were compared with antibodies in 25 matched healthy controls after second vaccination. In 36 kidney transplant recipients with seroconversion, neutralization against B.1.1.7 (\n                      <jats:italic toggle=\"yes\">\u03b1<\/jats:italic>\n                      ), B.1.351 (\n                      <jats:italic toggle=\"yes\">\u03b2<\/jats:italic>\n                      ), and B.1.617.2 (\n                      <jats:italic toggle=\"yes\">\u03b4<\/jats:italic>\n                      ) was determined on VeroE6 cells and compared with neutralization in 25 healthy controls.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      Kidney transplant recipients had significantly lower seroconversion rates compared with healthy controls. After the second vaccination, antispike 1, antireceptor-binding domain, and surrogate neutralizing antibodies were detectable in 30%, 27%, and 24% of kidney transplant recipients, respectively. This compares with 100%, 96%, and 100% in healthy controls, respectively (\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      &lt;0.001). Neutralization against B.1.1.7 was detectable in all kidney transplant recipients with seroconversion, with a median serum dilution that reduces infection of cells by 50% of 80 (interquartile range, 80\u2013320). In contrast, only 23 of 36 (64%) and 24 of 36 (67%) kidney transplant recipients showed neutralization against B.1.351 and B.1.617.2, respectively, with median serum dilutions that reduce infection of cells by 50% of 20 (interquartile range, 0\u201340) and 20 (interquartile range, 0\u201340), respectively. Neutralization against different variants was significantly higher in healthy controls (\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      &lt;0.001), with all patients showing neutralization against all tested variants.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Seroconverted kidney transplant recipients show impaired neutralization against emerging variants of concern after standard two-dose vaccination.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Clinical Trial registry name and registration number:<\/jats:title>\n                    <jats:p>Observational study to assess the SARS-CoV-2 specific immune response in kidney transplant recipients (COVID-19 related immune response), DRKS00024668<\/jats:p>\n                  <\/jats:sec>","DOI":"10.2215\/cjn.11820921","type":"journal-article","created":{"date-parts":[[2021,12,22]],"date-time":"2021-12-22T15:45:22Z","timestamp":1640187922000},"page":"98-106","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":24,"title":["Neutralization of SARS-CoV-2 Variants of Concern in Kidney Transplant Recipients after Standard COVID-19 Vaccination"],"prefix":"10.2215","volume":"17","author":[{"given":"Louise","family":"Benning","sequence":"first","affiliation":[{"name":"Department of Nephrology, University of Heidelberg, Heidelberg, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christian","family":"Morath","sequence":"additional","affiliation":[{"name":"Department of Nephrology, University of Heidelberg, Heidelberg, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marie","family":"Bartenschlager","sequence":"additional","affiliation":[{"name":"Department of Infectious Diseases, Molecular Virology, University of Heidelberg, Heidelberg, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christian","family":"Nusshag","sequence":"additional","affiliation":[{"name":"Department of Nephrology, University of Heidelberg, Heidelberg, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Florian","family":"K\u00e4lble","sequence":"additional","affiliation":[{"name":"Department of Nephrology, University of Heidelberg, Heidelberg, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mirabel","family":"Buylaert","sequence":"additional","affiliation":[{"name":"Department of Nephrology, University of Heidelberg, Heidelberg, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthias","family":"Schaier","sequence":"additional","affiliation":[{"name":"Department of Nephrology, University of Heidelberg, Heidelberg, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J\u00f6rg","family":"Beimler","sequence":"additional","affiliation":[{"name":"Department of Nephrology, University of Heidelberg, Heidelberg, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katrin","family":"Klein","sequence":"additional","affiliation":[{"name":"Department of Nephrology, University of Heidelberg, Heidelberg, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julia","family":"Grenz","sequence":"additional","affiliation":[{"name":"Department of Nephrology, University of Heidelberg, Heidelberg, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paula","family":"Reichel","sequence":"additional","affiliation":[{"name":"Department of Nephrology, University of Heidelberg, Heidelberg, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Asa","family":"Hidmark","sequence":"additional","affiliation":[{"name":"Department of Nephrology, University of Heidelberg, Heidelberg, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gerald","family":"Ponath","sequence":"additional","affiliation":[{"name":"Department of Nephrology, University of Heidelberg, Heidelberg, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maximilian","family":"T\u00f6llner","sequence":"additional","affiliation":[{"name":"Department of Nephrology, University of Heidelberg, Heidelberg, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marvin","family":"Reineke","sequence":"additional","affiliation":[{"name":"Department of Nephrology, University of Heidelberg, Heidelberg, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susanne","family":"Rieger","sequence":"additional","affiliation":[{"name":"Department of Pediatrics I, University Children\u2019s Hospital Heidelberg, Heidelberg, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Burkhard","family":"T\u00f6nshoff","sequence":"additional","affiliation":[{"name":"Department of Pediatrics I, University Children\u2019s Hospital Heidelberg, Heidelberg, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul","family":"Schnitzler","sequence":"additional","affiliation":[{"name":"Department of Infectious Diseases, Virology, University of Heidelberg, Heidelberg, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin","family":"Zeier","sequence":"additional","affiliation":[{"name":"Department of Nephrology, University of Heidelberg, Heidelberg, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Caner","family":"S\u00fcsal","sequence":"additional","affiliation":[{"name":"Institute of Immunology, University of Heidelberg, Heidelberg, Germany"},{"name":"Transplant Immunology Research Center of Excellence, Ko\u00e7 \u00dcniversitesi Hastanesi, Istanbul, Turkey"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5601-9307","authenticated-orcid":false,"given":"Ralf","family":"Bartenschlager","sequence":"additional","affiliation":[{"name":"Department of Infectious Diseases, Molecular Virology, University of Heidelberg, Heidelberg, Germany"},{"name":"German Center for Infection Research, Heidelberg Partner Site, Heidelberg, Germany"},{"name":"Division of Virus-Associated Carcinogenesis, German Cancer Research Center, Heidelberg, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claudius","family":"Speer","sequence":"additional","affiliation":[{"name":"Department of Nephrology, University of Heidelberg, Heidelberg, Germany"},{"name":"Molecular Medicine Partnership Unit Heidelberg, European Molecular Biology Laboratory, Heidelberg, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2022,1]]},"reference":[{"key":"B1-20241015","doi-asserted-by":"crossref","first-page":"1973","DOI":"10.1093\/ndt\/gfaa261","article-title":"COVID-19-related mortality in kidney transplant and dialysis patients: Results of the ERACODA collaboration","volume":"35","author":"Hilbrands","year":"2020","journal-title":"Nephrol Dial Transplant"},{"key":"B2-20241015","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1038\/s41586-020-2521-4","article-title":"Factors associated with COVID-19-related death using OpenSAFELY","volume":"584","author":"Williamson","year":"2020","journal-title":"Nature"},{"key":"B3-20241015","doi-asserted-by":"crossref","first-page":"2147","DOI":"10.1681\/ASN.2021040480","article-title":"Antibody and T cell response to SARS-CoV-2 messenger RNA BNT162b2 vaccine in kidney transplant recipients and hemodialysis patients","volume":"32","author":"Bertrand","year":"2021","journal-title":"J Am Soc Nephrol"},{"key":"B4-20241015","doi-asserted-by":"crossref","first-page":"2153","DOI":"10.1681\/ASN.2021040490","article-title":"Humoral response after SARS-CoV-2 mRNA vaccination in a cohort of hemodialysis patients and kidney transplant recipients","volume":"32","author":"Danthu","year":"2021","journal-title":"J Am Soc Nephrol"},{"key":"B5-20241015","doi-asserted-by":"crossref","first-page":"150175","DOI":"10.1172\/JCI150175","article-title":"Impaired humoral and cellular immunity after SARS-CoV-2 BNT162b2 (tozinameran) prime-boost vaccination in kidney transplant recipients","volume":"131","author":"Sattler","year":"2021","journal-title":"J Clin Invest"},{"key":"B6-20241015","doi-asserted-by":"crossref","first-page":"eabj1031","DOI":"10.1126\/sciimmunol.abj1031","article-title":"Impaired humoral immunity to SARS-CoV-2 BNT162b2 vaccine in kidney transplant recipients and dialysis patients","volume":"6","author":"Rincon-Arevalo","year":"2021","journal-title":"Sci Immunol"},{"key":"B7-20241015","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.2215\/CJN.03700321","article-title":"Early humoral responses of hemodialysis patients after COVID-19 vaccination with BNT162b2","volume":"16","author":"Speer","year":"2021","journal-title":"Clin J Am Soc Nephrol"},{"key":"B8-20241015","doi-asserted-by":"crossref","first-page":"e72","DOI":"10.1097\/TP.0000000000003764","article-title":"Kidney transplant recipients rarely show an early antibody response following the first COVID-19 vaccine administration","volume":"105","author":"Yi","year":"2021","journal-title":"Transplantation"},{"key":"B9-20241015","doi-asserted-by":"crossref","first-page":"1498","DOI":"10.1016\/j.kint.2021.04.005","article-title":"Low immunization rates among kidney transplant recipients who received 2 doses of the mRNA-1273 SARS-CoV-2 vaccine","volume":"99","author":"Benotmane","year":"2021","journal-title":"Kidney Int"},{"key":"B10-20241015","doi-asserted-by":"crossref","first-page":"2727","DOI":"10.1111\/ajt.16701","article-title":"Cellular and humoral response after MRNA-1273 SARS-CoV-2 vaccine in kidney transplant recipients","volume":"21","author":"Cucchiari","year":"2021","journal-title":"Am J Transplant"},{"key":"B11-20241015","doi-asserted-by":"crossref","first-page":"721286","DOI":"10.3389\/fmed.2021.721286","article-title":"Humoral responses to single-dose BNT162b2 mRNA vaccination in dialysis patients previously infected with SARS-CoV-2","volume":"8","author":"Speer","year":"2021","journal-title":"Front Med (Lausanne)"},{"key":"B12-20241015","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1056\/NEJMc2108861","article-title":"Three doses of an mRNA Covid-19 vaccine in solid-organ transplant recipients","volume":"385","author":"Kamar","year":"2021","journal-title":"N Engl J Med"},{"key":"B13-20241015","doi-asserted-by":"crossref","first-page":"1244","DOI":"10.1056\/NEJMc2111462","article-title":"Randomized trial of a third dose of mRNA-1273 vaccine in transplant recipients","volume":"385","author":"Hall","year":"2021","journal-title":"N Engl J Med"},{"key":"B14-20241015","doi-asserted-by":"crossref","first-page":"1474","DOI":"10.1056\/NEJMoa2109072","article-title":"Covid-19 breakthrough infections in vaccinated health care workers","volume":"385","author":"Bergwerk","year":"2021","journal-title":"N Engl J Med"},{"key":"B15-20241015","doi-asserted-by":"crossref","first-page":"2140","DOI":"10.1681\/ASN.2021020188","article-title":"Hemodialysis patients make long-lived antibodies against SARS-CoV-2 that may be associated with reduced reinfection","volume":"32","author":"Banham","year":"2021","journal-title":"J Am Soc Nephrol"},{"key":"B16-20241015","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1038\/s41586-021-03693-y","article-title":"BNT162b2-elicited neutralization of B.1.617 and other SARS-CoV-2 variants","volume":"596","author":"Liu","year":"2021","journal-title":"Nature"},{"key":"B17-20241015","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1038\/s41591-021-01270-4","article-title":"Neutralization of SARS-CoV-2 spike 69\/70 deletion, E484K and N501Y variants by BNT162b2 vaccine-elicited sera","volume":"27","author":"Xie","year":"2021","journal-title":"Nat Med"},{"key":"B18-20241015","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1038\/s41591-021-01294-w","article-title":"Resistance of SARS-CoV-2 variants to neutralization by monoclonal and serum-derived polyclonal antibodies","volume":"27","author":"Chen","year":"2021","journal-title":"Nat Med"},{"key":"B19-20241015","doi-asserted-by":"crossref","first-page":"2331","DOI":"10.1016\/S0140-6736(21)01290-3","article-title":"Neutralising antibody activity against SARS-CoV-2 VOCs B.1.617.2 and B.1.351 by BNT162b2 vaccination","volume":"397","author":"Wall","year":"2021","journal-title":"Lancet"},{"key":"B20-20241015","doi-asserted-by":"crossref","first-page":"1379","DOI":"10.1038\/s41591-021-01413-7","article-title":"Evidence for increased breakthrough rates of SARS-CoV-2 variants of concern in BNT162b2-mRNA-vaccinated individuals","volume":"27","author":"Kustin","year":"2021","journal-title":"Nat Med"},{"key":"B21-20241015","article-title":"Variants of concern are overrepresented among post-vaccination breakthrough infections of SARS-CoV-2 in Washington State","author":"McEwen","journal-title":"Clin Infect Dis"},{"key":"B22-20241015","doi-asserted-by":"crossref","first-page":"700","DOI":"10.1016\/j.kint.2021.07.002","article-title":"Neutralizing antibody response against variants of concern after vaccination of dialysis patients with BNT162b2","volume":"100","author":"Speer","year":"2021","journal-title":"Kidney Int"},{"key":"B23-20241015","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1053\/j.ajkd.2021.05.004","article-title":"Clinically significant COVID-19 following SARS-CoV-2 vaccination in kidney transplant recipients","volume":"78","author":"Tsapepas","year":"2021","journal-title":"Am J Kidney Dis"},{"key":"B24-20241015","doi-asserted-by":"crossref","first-page":"e13710","DOI":"10.1111\/tid.13710","article-title":"A case of severe COVID-19 despite full vaccination with mRNA-1273 SARS-CoV-2 vaccine (Moderna) in a kidney transplant recipient","volume":"23","author":"Chang","year":"2021","journal-title":"Transpl Infect Dis"},{"key":"B25-20241015","article-title":"COVID-19 after two doses of mRNA vaccines in kidney transplant recipients","author":"Mehta","journal-title":"Am J Transplant"},{"key":"B26-20241015","doi-asserted-by":"crossref","first-page":"1024","DOI":"10.1016\/j.cell.2020.09.037","article-title":"Mapping neutralizing and immunodominant sites on the SARS-CoV-2 spike receptor-binding domain by structure-guided high-resolution serology","volume":"183","author":"Piccoli","year":"2020","journal-title":"Cell"},{"key":"B27-20241015","doi-asserted-by":"crossref","first-page":"857","DOI":"10.3390\/vaccines9080857","article-title":"Heterologous ChAdOx1 nCoV-19\/BNT162b2 prime-boost vaccination induces strong humoral responses among health care workers","volume":"9","author":"Benning","year":"2021","journal-title":"Vaccines (Basel)"},{"key":"B28-20241015","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.1038\/s41587-020-0631-z","article-title":"A SARS-CoV-2 surrogate virus neutralization test based on antibody-mediated blockage of ACE2-spike protein-protein interaction","volume":"38","author":"Tan","year":"2020","journal-title":"Nat Biotechnol"},{"key":"B29-20241015","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1097\/TP.0000000000003524","article-title":"Development and validation of a multiplex, bead-based assay to detect antibodies directed against SARS-CoV-2 proteins","volume":"105","author":"Bray","year":"2021","journal-title":"Transplantation"},{"key":"B30-20241015","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1001\/jamapediatrics.2021.0001","article-title":"Prevalence of SARS-CoV-2 infection in children and their parents in southwest Germany","volume":"175","author":"T\u00f6nshoff","year":"2021","journal-title":"JAMA Pediatr"},{"key":"B31-20241015","doi-asserted-by":"crossref","first-page":"2032","DOI":"10.1038\/s41591-021-01540-1","article-title":"Correlates of protection against symptomatic and asymptomatic SARS-CoV-2 infection","volume":"27","author":"Feng","year":"2021","journal-title":"Nat Med"},{"key":"B32-20241015","doi-asserted-by":"crossref","first-page":"1205","DOI":"10.1038\/s41591-021-01377-8","article-title":"Neutralizing antibody levels are highly predictive of immune protection from symptomatic SARS-CoV-2 infection","volume":"27","author":"Khoury","year":"2021","journal-title":"Nat Med"},{"key":"B33-20241015","doi-asserted-by":"crossref","first-page":"100178","DOI":"10.1016\/j.lanepe.2021.100178","article-title":"Humoral and cellular immunity to SARS-CoV-2 vaccination in renal transplant versus dialysis patients: A prospective, multicenter observational study using mRNA-1273 or BNT162b2 mRNA vaccine","volume":"9","author":"Stumpf","year":"2021","journal-title":"Lancet Reg Health Eur"}],"container-title":["Clinical Journal of the American Society of Nephrology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.2215\/CJN.11820921","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,10]],"date-time":"2026-08-10T13:45:31Z","timestamp":1786369531000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.2215\/CJN.11820921"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,1]]},"references-count":33,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2022]]}},"URL":"https:\/\/doi.org\/10.2215\/cjn.11820921","relation":{},"ISSN":["1555-9041","1555-905X"],"issn-type":[{"value":"1555-9041","type":"print"},{"value":"1555-905X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,1]]},"assertion":[{"value":"2021-09-03","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2021-11-01","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}